CN111588698A - 一种提高水溶性的氟苯尼考粉剂及其制备方法和应用 - Google Patents
一种提高水溶性的氟苯尼考粉剂及其制备方法和应用 Download PDFInfo
- Publication number
- CN111588698A CN111588698A CN202010577223.XA CN202010577223A CN111588698A CN 111588698 A CN111588698 A CN 111588698A CN 202010577223 A CN202010577223 A CN 202010577223A CN 111588698 A CN111588698 A CN 111588698A
- Authority
- CN
- China
- Prior art keywords
- parts
- florfenicol
- florfenicol powder
- powder
- water solubility
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- AYIRNRDRBQJXIF-NXEZZACHSA-N (-)-Florfenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)C=C1 AYIRNRDRBQJXIF-NXEZZACHSA-N 0.000 title claims abstract description 92
- 229960003760 florfenicol Drugs 0.000 title claims abstract description 92
- 239000000843 powder Substances 0.000 title claims abstract description 74
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 50
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 75
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 29
- 239000008101 lactose Substances 0.000 claims abstract description 29
- IIZVTUWSIKTFKO-UHFFFAOYSA-N 2-hydroxypropanoic acid;5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine Chemical compound CC(O)C(O)=O.COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IIZVTUWSIKTFKO-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229960001937 trimethoprim lactate Drugs 0.000 claims abstract description 27
- 229940093429 polyethylene glycol 6000 Drugs 0.000 claims abstract description 26
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims abstract description 26
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims abstract description 26
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims abstract description 26
- 235000019482 Palm oil Nutrition 0.000 claims abstract description 24
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims abstract description 24
- 239000002540 palm oil Substances 0.000 claims abstract description 24
- 239000000203 mixture Substances 0.000 claims description 31
- 238000007873 sieving Methods 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 11
- 239000012153 distilled water Substances 0.000 claims description 9
- 238000001694 spray drying Methods 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 7
- 238000005303 weighing Methods 0.000 claims description 7
- 229940124350 antibacterial drug Drugs 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 7
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract description 5
- 239000003814 drug Substances 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 9
- 241000282887 Suidae Species 0.000 description 7
- 239000006184 cosolvent Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 235000019629 palatability Nutrition 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 208000021017 Weight Gain Diseases 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001626 effect on respiratory system Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960003053 thiamphenicol Drugs 0.000 description 1
- OTVAEFIXJLOWRX-NXEZZACHSA-N thiamphenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)C=C1 OTVAEFIXJLOWRX-NXEZZACHSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010577223.XA CN111588698B (zh) | 2020-06-23 | 2020-06-23 | 一种提高水溶性的氟苯尼考粉剂及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010577223.XA CN111588698B (zh) | 2020-06-23 | 2020-06-23 | 一种提高水溶性的氟苯尼考粉剂及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111588698A true CN111588698A (zh) | 2020-08-28 |
CN111588698B CN111588698B (zh) | 2022-06-24 |
Family
ID=72179765
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010577223.XA Active CN111588698B (zh) | 2020-06-23 | 2020-06-23 | 一种提高水溶性的氟苯尼考粉剂及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111588698B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112641730A (zh) * | 2021-02-19 | 2021-04-13 | 山东鲁抗舍里乐药业有限公司高新区分公司 | 一种可溶氟苯尼考粉的制备方法 |
CN116036020A (zh) * | 2022-08-31 | 2023-05-02 | 瑞普(天津)生物药业有限公司 | 一种高生物利用度的氟苯尼考粉剂及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110152312A1 (en) * | 2009-12-17 | 2011-06-23 | Le Hir De Fallois Loic Patrick | Antiparisitic dihydroazole compounds and compositions comprising same |
CN106390136A (zh) * | 2016-08-31 | 2017-02-15 | 河北维尔利动物药业集团有限公司 | 一种高生物利用度的水溶性氟苯尼考包合物及其制备方法 |
CN107157974A (zh) * | 2017-06-12 | 2017-09-15 | 南京大方生物工程有限公司 | 一种氟苯尼考粉散剂及其制备方法 |
CN108210464A (zh) * | 2016-12-13 | 2018-06-29 | 河南后羿实业集团有限公司 | 一种复方氟苯尼考可溶性粉剂及其制备方法 |
CN110917142A (zh) * | 2018-09-20 | 2020-03-27 | 临沂文一诺知识产权运营有限公司 | 一种氟苯尼考可溶性粉粉剂药物 |
-
2020
- 2020-06-23 CN CN202010577223.XA patent/CN111588698B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110152312A1 (en) * | 2009-12-17 | 2011-06-23 | Le Hir De Fallois Loic Patrick | Antiparisitic dihydroazole compounds and compositions comprising same |
CN106390136A (zh) * | 2016-08-31 | 2017-02-15 | 河北维尔利动物药业集团有限公司 | 一种高生物利用度的水溶性氟苯尼考包合物及其制备方法 |
CN108210464A (zh) * | 2016-12-13 | 2018-06-29 | 河南后羿实业集团有限公司 | 一种复方氟苯尼考可溶性粉剂及其制备方法 |
CN107157974A (zh) * | 2017-06-12 | 2017-09-15 | 南京大方生物工程有限公司 | 一种氟苯尼考粉散剂及其制备方法 |
CN110917142A (zh) * | 2018-09-20 | 2020-03-27 | 临沂文一诺知识产权运营有限公司 | 一种氟苯尼考可溶性粉粉剂药物 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112641730A (zh) * | 2021-02-19 | 2021-04-13 | 山东鲁抗舍里乐药业有限公司高新区分公司 | 一种可溶氟苯尼考粉的制备方法 |
CN116036020A (zh) * | 2022-08-31 | 2023-05-02 | 瑞普(天津)生物药业有限公司 | 一种高生物利用度的氟苯尼考粉剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN111588698B (zh) | 2022-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111588698B (zh) | 一种提高水溶性的氟苯尼考粉剂及其制备方法和应用 | |
NZ543594A (en) | Compositions for treating infection in cattle and swine comprising a fluorinated chloramphenicol or thiamphenicol derivative antibiotic such as florfenicol, and triacetin | |
CN102697784B (zh) | 一种兽用恩诺沙星注射液及其制备方法 | |
CN110787131A (zh) | 一种氟苯尼考可溶性粉制剂的制备方法 | |
CN107773554A (zh) | 一种伊维菌素缓释微囊及其制备方法和应用 | |
CN104288222B (zh) | 一种治疗奶牛子宫内膜炎的纳米药物及其制备方法 | |
JP2013542737A (ja) | 昆虫侵入を阻害するための方法 | |
Dorrestein et al. | Clinical pharmacology and pharmacokinetics of flumequine after intravenous, intramuscular and oral administration in pigeons (Columba livid) | |
CN104161761B (zh) | 一种复方土霉素注射液及其制备方法 | |
CN106620668A (zh) | 一种复方替米考星固体分散剂及其制备方法 | |
CN104983686A (zh) | 畜禽用美洛昔康可溶性粉剂及其制备方法 | |
CN106727315A (zh) | 一种盐酸溴己新纳米乳液及其制备方法 | |
US4912138A (en) | Pharmaceutical preparation containing thiamphenicol for veterinary use | |
CN102106815A (zh) | 一种氟苯尼考溶液及其制备方法 | |
CN111568861A (zh) | 畜禽用盐酸溴己新口服液及其制备方法和应用 | |
CN111759854A (zh) | 用于治疗动物呼吸道疾病的注射液组合物及其制备方法 | |
CN114557999B (zh) | 一种治疗牦牛焦虫病的药物及其制备方法和应用 | |
CN111249232A (zh) | 一种30%氟苯尼考混悬液及其制备方法 | |
JP2002505257A (ja) | ベンゾイルフェニル尿素を含む殺菌剤組成物 | |
CN1943554A (zh) | 一种阿维菌素透皮剂及制备方法 | |
CN112972437B (zh) | 一种包含碘硝酚的长效外用制剂及其制备方法和用途 | |
CN109394679B (zh) | 一种用于动物蹄病的利福昔明软膏 | |
CN116570556B (zh) | 一种用于治疗畜禽大肠埃希菌和巴氏杆菌感染的复方磺胺氯达嗪钠溶液及其制备方法 | |
Yue et al. | Dosage Regimen Formulation and Therapeutic Effect Evaluation of Cyadox Nanosuspension Against Dairy Cow Mastitis Caused by Staphylococcus aureus | |
CN108653262B (zh) | 酮洛芬外用药物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240205 Address after: Building 0026, G48, East Side of Tai Road and North Side of Xinyang Road, China Pharmaceutical City, Taizhou Medical High tech Industrial Development Zone, Jiangsu Province, 225316 Patentee after: Jiangsu Dafang Biotechnology Co.,Ltd. Country or region after: China Address before: 211111 No.1-2, Wangyuan Road, moling Industrial Park, Jiangning District, Nanjing City, Jiangsu Province Patentee before: NANJING DAFANG BIOENGINEERING Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |